Lee Jennifer Kayden bought RYTM
August 13, 2026 · Form 4 insider transaction
Lee Jennifer Kayden bought 35,000 shares of Rhythm Pharmaceuticals, Inc. at $24.29 per share, a transaction worth $850.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
35,000
Price
$24.29
Total value
$850.1K
InsiderLee Jennifer Kayden
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 13, 2026
Filing dateAugust 14, 2026
Shares owned after54,233
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The exercises and sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2026.